Measures used to treat contrast-induced nephropathy: overview of reviews - Wikidata - wikimedia - TriplyDB

Measures used to treat contrast-induced nephropathy: overview of reviews

Measures used to treat contrast-induced nephropathy: overview of reviews

http://www.wikidata.org/entity/Q26849704

about

Risk prediction models for contrast induced nephropathy: systematic review Nonpharmacological strategies to prevent contrast-induced acute kidney injury Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial.The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathy Sodium Bicarbonate Prevents Contrast-Induced Nephropathy in Addition to Theophylline: A Randomized Controlled Trial.Effect of remote ischaemic conditioning on contrast-induced nephropathy in patients undergoing elective coronary angiography (ERICCIN): rationale and study design of a randomised single-centre, double-blind placebo-controlled trial.Pharmacological strategies to prevent contrast-induced acute kidney injury.The prevention of contrast-induced nephropathy.Accuracy of point-of-care serum creatinine devices for detecting patients at risk of contrast-induced nephropathy: a critical overview.Statins in the prevention of contrast-induced nephropathy.Renal-related adverse effects of intravenous contrast media in computed tomography.Ameliorative effect of melatonin against contrast media induced renal tubular cell injury.Preprocedural Prediction Model for Contrast-Induced Nephropathy Patients.Antioxidant and renoprotective effects of sphingosylphosphorylcholine on contrast-induced nephropathy in rats.Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy.Short term high dose atorvastatin for the prevention of contrast-induced nephropathy in patients undergoing computed tomography angiography.Additional furosemide treatment beyond saline hydration for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials.

P2860

Q26796473-D805B81E-771D-4CF7-8F9C-3F326D21A5BB Q27023336-B4EF81C0-D069-47C4-814B-42013AC70B6A Q34257105-F2BB94FD-F9C4-43E5-A5ED-3D04D0BC6978 Q35666177-82B12992-873B-42F3-9991-5796395FB9CC Q36389997-A7110F5A-9C78-4117-BBB6-B4D3321769AB Q36992907-52EFBB7F-E994-45B0-B933-5E6841743601 Q37608257-841B8B2D-2670-4895-8FF7-E001CD8B80F2 Q37639849-A9179BD1-B8A4-4598-B532-8EEDA78CD29A Q38226255-964ECF97-A8AF-4050-A5BD-C5796468C761 Q38230626-EC1F0AF9-38B6-4469-8F96-D256FD99E258 Q38380615-4ED7329B-8863-4533-B160-C53E0A5E155A Q38445166-A21BAB46-B225-4303-808D-F9FB89579C23 Q38954865-22271F90-19EF-49C1-9584-E7A0BC7B5DD8 Q38979950-26A19D39-B048-4981-BF53-C2CC0D801FCB Q39679016-3ED00EDF-D1CC-4C29-8D73-BBDA60FA6C62 Q42567312-55EADD8C-E456-46A3-9F03-11D4517657D4 Q43049960-A6A87F25-47A6-40BE-A577-C5213CFEDB04 Q43185032-DBA6B41E-C297-4043-A2EE-B18B5CCAA89D

P2860

Measures used to treat contrast-induced nephropathy: overview of reviews

http://www.wikidata.org/entity/Q26849704

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Measures used to treat contrast-induced nephropathy: overview of reviews

@ast

Measures used to treat contrast-induced nephropathy: overview of reviews

@en

Measures used to treat contrast-induced nephropathy: overview of reviews

@nl

type

label

Measures used to treat contrast-induced nephropathy: overview of reviews

@ast

Measures used to treat contrast-induced nephropathy: overview of reviews

@en

Measures used to treat contrast-induced nephropathy: overview of reviews

@nl

prefLabel

Measures used to treat contrast-induced nephropathy: overview of reviews

@ast

Measures used to treat contrast-induced nephropathy: overview of reviews

@en

Measures used to treat contrast-induced nephropathy: overview of reviews

@nl

P1433

Q26849704-C5C98D22-3382-4229-96DC-FC2FCE0521AB

P1476

Q26849704-EBD744EB-CCC9-47C2-9ECA-8B7EA029CD8A

P2093

Q26849704-37F130E3-9636-4DB0-8509-4FA153031492

Q26849704-4AF5AB41-BE09-4184-8866-897DB3BCC2AB

Q26849704-4B351F75-DD4E-41FA-9ADA-4AF4555E828A

P2860

Q26849704-06B34CDB-BD1F-4398-AA96-9BBA6355B75A

Q26849704-08A728CD-CE6D-439B-B7C7-73CA577E616C

Q26849704-09A7786F-97B3-49EE-8174-3E8B8788239F

Q26849704-1060953B-BEA9-4D1B-862D-608A6C9533AC

Q26849704-19EC4D4D-2DBE-4DD8-A6FF-10200E4BC9E8

Q26849704-3EBC3662-CB7E-4DAA-A443-26C405C95927

Q26849704-45977EC5-81F7-4637-B3F2-9E1D49231F77

Q26849704-4CD59492-315E-4ED0-89A3-34BA90D49C15

Q26849704-4F356EEF-C71F-422B-971D-F07C1BFB4918

Q26849704-5B3D8CF1-FBE9-447D-902C-9426A402BF8A

P304

Q26849704-ECC9D30D-2E99-4388-8520-E00BF055880B

P31

Q26849704-E3B95876-E768-4BB6-9340-F3DEA6D8646A

Q26849704-ae9f0de5-9203-4f5a-a2f7-9f0c322cd327

P3181

Q26849704-850B29A7-7EA4-476F-992D-13FDDD4F7357

P356

Q26849704-F6495A59-7820-488E-AEF2-2E82C9E19E98

P407

Q26849704-A509EB36-9518-41F0-BA13-EC499763634D

P433

Q26849704-17A81E58-F142-4EEF-8066-B2A01D93F1DA

P478

Q26849704-57118421-84B4-478A-9E04-F2B66CEDEE1E

P50

Q26849704-8DE9206D-5BC4-424B-B7E1-4BC3C82FCCE1

P577

Q26849704-5EBCF47B-8128-4A87-9D50-123EE656F724

P698

Q26849704-3BA4FC78-42C4-4EE2-96E1-1C306C2FB156

P932

Q26849704-CE6CA51F-264C-4A7C-A556-58B1EFAAC5C4

P3181

P356

P1433

British Journal of Radiology

P1476

Measures used to treat contrast-induced nephropathy: overview of reviews

@en

P2093

C S Kwok

http://www.w3.org/2001/XMLSchema#string

J K Yeong

http://www.w3.org/2001/XMLSchema#string

Y K Loke

http://www.w3.org/2001/XMLSchema#string

P2860

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.

Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).

Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia.

Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).

N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.

Epidemiology and prognostic implications of contrast-induced nephropathy.

Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy.

Statin effects beyond lipid lowering--are they clinically relevant?

P304

20120272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1935830

http://www.w3.org/2001/XMLSchema#string

P356

10.1259/BJR.20120272

http://www.w3.org/2001/XMLSchema#string

P407

P433

1021

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23239696

http://www.w3.org/2001/XMLSchema#string

P932

3615404

http://www.w3.org/2001/XMLSchema#string